ProCE Banner Activity

Paths to Elimination: Simplifying Screening and Treatment of Viral Hepatitis in Priority Populations

Video

In this webcast, learn strategies to improve screening rates and apply guideline-concordant care in people with viral hepatitis. Learn as experts discuss how to improve engagement in HBV care for priority populations and provide HCV care in nontraditional settings.

Released: February 21, 2025

Expiration: February 20, 2026

Share

Provided by

Provided by Clinical Care Options, LLC, in partnership with the Asian Health Foundation, Hepatitis B Foundation, and HealthHCV.

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Partners

AHF

ProCE Banner

Health HCV

ProCE Banner

Hepatitis B Foundation

ProCE Banner

Faculty Disclosure

Primary Author

Patricia D. Jones, MD, MSCR

Associate Professor of Clinical Medicine
Director of Clinical Operations-Hepatology
Division of Digestive Health and Liver Diseases
Department of Medicine
University of Miami Miller School of Medicine
Sylvester Comprehensive Cancer Center
Miami, Florida

Patricia D. Jones, MD, MSCR, has no relevant financial relationships to disclose.

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

Professor of Medicine (GI & Hepatology, Liver Transplant)
Professor of Epidemiology & Population Health
(by Courtesy)
Director of Hepatology Clerkship
Faculty Search LENS Advocates,
Stanford Department of Medicine
Faculty Fellow, Stanford Center for Innovation
in Global Health
Member, Stanford Cancer Institute, Maternal &
Child Health Research Institute, & Stanford Bio-C
Stanford, California
Past Chair: HBV SIG, The American Association for the Study of Liver Diseases (AASLD)
28th President: The International Association for the Study of the Liver (IASL)

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD: researcher: AstraZeneca, CurveBio, Delfi, Enanta, Exact Sciences, Gilead, GlaxoSmithKline, Glycotest, Helio Health, InnoGen, Pfizer, Vir Biotech; consultant/advisor: Exelixis.

Jennifer Wild, MS, BSN, RN, OCN

Clinical Nurse – GI Medical Oncology
UCSF Cancer Center
San Francisco, California

Jennifer Wild, MS, RN, OCN: consultant/advisor/speaker: AstraZeneca.